Copper oxodotreotide Cu-64

未找到该活性成分的已注册品牌。

• 用液体送服。使用 copper Cu 64 dotatate 显像前后，患者应保持充足的水化，以限制辐射暴露。

  模板翻译

• Lanreotide轻微

  当 Lanreotide 与 Copper oxodotreotide Cu-64 联合使用时，Lanreotide 的治疗效果可能减弱。

  专业视图

  The therapeutic efficacy of Lanreotide can be decreased when used in combination with Copper oxodotreotide Cu-64.

• Octreotide轻微

  当 Octreotide 与 Copper oxodotreotide Cu-64 联合使用时，Octreotide 的治疗效果可能减弱。

  专业视图

  The therapeutic efficacy of Octreotide can be decreased when used in combination with Copper oxodotreotide Cu-64.

• Pasireotide轻微

  当 Pasireotide 与 Copper oxodotreotide Cu-64 联合使用时，Pasireotide 的治疗效果可能减弱。

  专业视图

  The therapeutic efficacy of Pasireotide can be decreased when used in combination with Copper oxodotreotide Cu-64.

• Somatostatin轻微

  当 Somatostatin 与 Copper oxodotreotide Cu-64 联合使用时，Somatostatin 的治疗效果可能减弱。

  专业视图

  The therapeutic efficacy of Somatostatin can be decreased when used in combination with Copper oxodotreotide Cu-64.

• Vapreotide轻微

  当 Vapreotide 与 Copper oxodotreotide Cu-64 联合使用时，Vapreotide 的治疗效果可能减弱。

  专业视图

  The therapeutic efficacy of Vapreotide can be decreased when used in combination with Copper oxodotreotide Cu-64.